Free tool
FAERS Monitor: Adderall Xr 10
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021303 or its brand name (Adderall Xr 10, Amphetamine Aspartate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate). Reports on generic versions are filed under their own applications.
Reports
41,907
Serious
18,198
43% of reports
Hospitalization
5,003
Death reported
515
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective4,838
- fatigue3,271
- nausea2,969
- headache2,700
- anxiety2,546
- depression2,150
- feeling abnormal2,034
- pain1,805
- dizziness1,792
- somnolence1,743
- insomnia1,642
- off label use1,517
- vomiting1,312
- malaise1,192
- weight decreased1,177
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 36 |
| 2005 | 38 |
| 2007 | 25 |
| 2008 | 5 |
| 2009 | 7 |
| 2010 | 25 |
| 2011 | 63 |
| 2012 | 374 |
| 2013 | 892 |
| 2014 | 1,261 |
| 2015 | 3,395 |
| 2016 | 7,276 |
| 2017 | 3,081 |
| 2018 | 3,384 |
| 2019 | 3,220 |
| 2020 | 2,918 |
| 2021 | 2,302 |
| 2022 | 2,889 |
| 2023 | 3,054 |
| 2024 | 2,862 |
| 2025 | 2,860 |
| 2026 | 1,940 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,012,252 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| depressionSignal | 2,150 | 4.8 | 4.6 | 6,428 |
| anxietySignal | 2,546 | 4.5 | 4.4 | 7,012 |
| somnolenceSignal | 1,743 | 4.4 | 4.2 | 4,537 |
| feeling abnormalSignal | 2,034 | 4.3 | 4.1 | 5,140 |
| insomniaSignal | 1,642 | 3.1 | 3.0 | 2,360 |
| headacheSignal | 2,700 | 2.2 | 2.1 | 1,739 |
| weight decreasedSignal | 1,177 | 2.1 | 2.0 | 702 |
| fatigueSignal | 3,271 | 2.1 | 2.0 | 1,983 |
| nausea | 2,969 | 1.9 | 1.8 | 1,279 |
| drug ineffective | 4,838 | 1.8 | 1.8 | 1,991 |
| dizziness | 1,792 | 1.8 | 1.7 | 657 |
| pain | 1,805 | 1.5 | 1.4 | 284 |
| vomiting | 1,312 | 1.4 | 1.3 | 154 |
| malaise | 1,192 | 1.4 | 1.3 | 118 |
| off label use | 1,517 | 0.9 | 0.8 | 31 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.